Moderately to Severely Active Ulcerative Colitis trials recruiting in New York

Fewer than 3 recruiting trials found.

All Moderately to Severely Active Ulcerative Colitis trials nationally

Cities in New York

Recruiting trials in New York

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · New York: Brooklyn, New York, North Massapequa, Queens Village
• A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
  NCT07158242 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · New York: Lake Success, New York